Moderna developing vaccine against monkeypox 

Moderna Inc. announced on Twitter that it is developing a vaccine against monkeypox, Report informs.

"In March of 2022, we announced our commitment to advancing programs by 2025 against pathogens that pose a threat to public health. Underscoring this commitment, and as monkeypox is of global public health importance as identified by the WHO, we are investigating potential monkeypox vaccines at a preclinical level," the company tweeted.